Contrast Enhanced Ultrasound Market Size & Growth Forecast 2026–2035, By Segments (Product, Type, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Contrast Enhanced Ultrasound Market size was estimated at USD 2.24 Billion in 2025 and is projected to grow at a 5.8% CAGR from 2026 to 2035, exceeding USD 3.94 Billion by 2035. The industry revenue for 2026 is assessed at USD 2.35 billion.
Get more details on this report
Request Free Sample ReportContrast Enhanced Ultrasound Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 36.68% market share in 2025, supported by advanced diagnostic infrastructure, broad availability of ultrasound systems, and established use of contrast-enhanced imaging in clinical practice.
- Asia Pacific is projected to expand at a 6.55% CAGR as healthcare capacity grows, diagnostic imaging access improves, and providers increasingly adopt efficient, cost-effective ultrasound technologies.
Segment Momentum
- Equipment accounted for 68.83% of the market in 2025 because providers prioritize installed ultrasound platforms that support routine imaging, workflow integration, and contrast-enhanced procedures over long replacement cycles.
- Contrast agents are growing fastest because demand rises with every contrast-enhanced procedure, creating recurring utilization that expands more rapidly than capital equipment purchasing cycles.
Market Expansion Drivers
- Rising cardiovascular and liver disease burden increasing diagnostic ultrasound demand.
- Adoption of radiation-free, cost-effective imaging alternatives to CT and MRI.
- Advancements in microbubble contrast agents improving imaging sensitivity and accuracy.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Leading players in the contrast enhanced ultrasound market include GE HealthCare (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Bracco Imaging S.p.A. (Italy), Lantheus Holdings, Inc. (United States), Canon Medical Systems Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Samsung Medison Co., Ltd. (South Korea), Esaote S.p.A. (Italy), Guerbet Group (France).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
A growing caseload of cardiac and hepatic disorders is pushing providers to expand imaging capacity that can support earlier lesion characterization, perfusion assessment, and follow-up without adding procedural complexity. In the contrast enhanced ultrasound market, this translates into stronger utilization in echocardiography and liver imaging, where clinicians often need real-time vascular detail to evaluate focal liver lesions, monitor cirrhosis-related complications, or improve endocardial border delineation in difficult-to-image patients. As these disease categories generate repeat diagnostic pathways rather than one-time scans, hospitals and specialty centers are reinforcing market demand by integrating contrast-enhanced protocols into routine ultrasound workflows.
Adoption of radiation-free, cost-effective imaging alternatives to CT and MRI
Pressure to reduce imaging costs while limiting patient exposure to ionizing radiation is shifting a portion of diagnostic decision-making toward ultrasound-based techniques that can answer targeted clinical questions quickly. The contrast enhanced ultrasound market benefits when radiology departments and referring physicians use contrast-enhanced ultrasound as a practical alternative for lesion characterization, bedside assessment, or follow-up imaging in patients for whom CT or MRI may be less suitable due to access constraints, renal concerns, or workflow delays. This adoption pattern is aiding market expansion by increasing procedure volumes in settings that prioritize faster turnaround and lower total imaging burden.
Advancements in microbubble contrast agents improving imaging sensitivity and accuracy
Improvements in microbubble formulation and imaging performance are making contrast-enhanced ultrasound more clinically dependable for detecting subtle vascular patterns and differentiating benign from malignant findings. In the contrast enhanced ultrasound market, better signal persistence, stronger enhancement behavior, and more precise visualization of blood flow give radiologists and sonographers greater confidence in using the modality for liver, cardiac, and other soft-tissue applications where diagnostic certainty shapes downstream treatment decisions. That increase in confidence is influencing market adoption at the protocol level, as facilities are more willing to standardize contrast-enhanced ultrasound in cases where conventional ultrasound alone may leave uncertainty.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cardiovascular and liver disease burden increasing diagnostic ultrasound demand | 2.00% | High | North America, Europe | High | Near Term |
| Adoption of radiation-free, cost-effective imaging alternatives to CT and MRI | 1.60% | Moderate | North America, Asia Pacific | High | Mid Term |
| Advancements in microbubble contrast agents improving imaging sensitivity and accuracy | 1.30% | High | North America, Europe | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 36.68% share of the contrast enhanced ultrasound market in 2025, supported by broad use of advanced diagnostic imaging in routine clinical practice and the region’s established healthcare infrastructure. Its leadership is aided by higher availability of ultrasound systems in hospitals and specialty centers, stronger integration of contrast-enhanced imaging into diagnostic workflows, and the presence of experienced clinicians able to apply the technology across liver, cardiac, and vascular assessments. These conditions sustain procedure volumes and support continued demand for upgraded imaging capabilities and related consumables.
Asia Pacific is projected to expand at a 6.55% CAGR over the forecast period, with growth in the contrast enhanced ultrasound market being fueled by rising access to diagnostic imaging and ongoing expansion of healthcare capacity across major regional economies. Adoption is accelerating as providers add imaging equipment, broaden hospital-based diagnostic services, and seek cost-effective modalities that can improve lesion characterization and real-time assessment without more complex imaging pathways. The region’s growth pattern is also shaped by increasing use of ultrasound in fast-growing urban healthcare networks where patient volumes are rising and diagnostic efficiency is becoming more important.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Contrast protocol standardizationGermany contrast enhanced ultrasound market is defined by protocol-driven adoption within radiology departments. In Germany, clinicians emphasize standardized CEUS protocols for liver lesion characterization, with strong hospital-based training and increasing use as a safer alternative to CT contrast imaging in patients with renal risk profiles.
France 🇫🇷
Refined vascular imaging adoptionFrance contrast enhanced ultrasound market is shaped by structured clinical adoption within public hospitals and specialist imaging centers. In France, CEUS is increasingly used for hepatic and vascular diagnostics, with emphasis on safety-focused imaging alternatives and gradual expansion into outpatient diagnostic pathways.
Italy 🇮🇹
Regional ultrasound utilizationItaly contrast enhanced ultrasound market relies on hospital-based diagnostic networks with strong focus on liver disease management. In Italy, adoption is concentrated in gastroenterology and radiology departments, where CEUS supports cost-effective imaging strategies amid regional disparities in access to advanced cross-sectional imaging.
Japan 🇯🇵
Efficiency-driven diagnosticsJapan contrast enhanced ultrasound market focuses on efficiency and minimally invasive diagnostics in aging care settings. In Japan, hospitals increasingly adopt CEUS for liver and vascular imaging to reduce patient burden, supported by strong ultrasound equipment penetration and workflow integration in routine diagnostic pathways.
South Korea 🇰🇷
Smart hospital ultrasound systemsSouth Korea contrast enhanced ultrasound market is supported by advanced hospital digital infrastructure and rapid imaging workflow adoption. In South Korea, tertiary hospitals integrate CEUS into comprehensive diagnostic packages, particularly for oncology and liver disease screening, leveraging skilled sonographers and high device utilization rates.
United States 🇺🇸
Point-of-care ultrasound expansionThe contrast enhanced ultrasound market in the United States is driven by growing adoption of point-of-care diagnostics and liver imaging applications. In the United States, clinicians increasingly integrate CEUS into emergency and oncology workflows to reduce dependence on CT contrast agents, supported by expanding training in advanced ultrasound interpretation across hospital systems.
Segment Leadership and Growth Trends
Contrast Enhanced Ultrasound Market Share (%), Product, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEquipment held the leading position in the contrast enhanced ultrasound market in 2025, accounting for a 68.83% share. This leadership is maintained through the installed base of ultrasound systems across hospitals and diagnostic centers, where equipment purchasing decisions are tied to long replacement cycles, workflow integration, and broad clinical utility beyond contrast procedures alone. In practice, providers prioritize platforms that can support routine imaging volumes while also enabling contrast-enhanced applications, which keeps Equipment at the center of spending in the contrast enhanced ultrasound market.
Contrast Agents are emerging as the fastest-growing product segment in the contrast enhanced ultrasound market because growth is directly linked to rising procedure adoption rather than slower capital equipment cycles. As more clinicians incorporate contrast-enhanced imaging into diagnostic pathways, demand for agents increases with each use, creating a more immediate expansion pattern than equipment procurement. This momentum is stronger relative to Equipment because Contrast Agents benefit from recurring utilization in clinical practice, making their growth closely aligned with day-to-day imaging activity.
Type Segment Analysis: Non-targeted (Largest Segment) vs Targeted (Fastest-Growing Segment)
By 2025, Non-targeted represented the largest share in the contrast enhanced ultrasound market. Its leading position reflects established clinical familiarity and broader routine use, as non-targeted approaches fit existing imaging workflows without requiring the added specificity associated with more specialized techniques. That practical ease of adoption supports continued volume leadership in the contrast enhanced ultrasound market, particularly where consistency, accessibility, and standard diagnostic application remain central to utilization.
Targeted is the fastest-growing type segment in the contrast enhanced ultrasound market, gaining traction as imaging needs become more precise and application-specific. Its momentum relative to Non-targeted is backed by the growing value placed on focused visualization in settings where conventional broad-use approaches may offer less differentiation. As clinical requirements shift toward more refined assessment, Targeted approaches are advancing from niche use toward wider adoption, which supports their faster growth trajectory.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Equipment, Contrast Agents | Equipment | Contrast Agents |
| Type | Non-targeted, Targeted | Non-targeted | Targeted |
| End Use | Hospitals, Clinics, Ambulatory Diagnostic Centers | Hospitals | Clinics |
Competitive Landscape and Market Positioning
1. GE HealthCare (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Bracco Imaging S.p.A. (Italy)
5. Lantheus Holdings Inc. (United States)
6. Canon Medical Systems Corporation (Japan)
7. Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
8. Samsung Medison Co. Ltd. (South Korea)
9. Esaote S.p.A. (Italy)
10. Guerbet Group (France)
In the contrast enhanced ultrasound market, improved imaging techniques are enabling more detailed visualization of vascular and tissue structures. Research initiatives are enhancing contrast agent performance and imaging clarity. Continuous product improvements are expanding clinical applicability across diagnostic procedures.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Fujifilm Healthcare Americas Corp. | Nov-25 | Fujifilm launched the EB-710US Ultrasound Bronchoscope, a balloon-less EBUS solution. This development improves clinical workflow efficiency and reduces infection risks associated with traditional disposable balloons, while simultaneously enhancing ultrasound visualization and tissue contact for more accurate diagnostic performance. |
| GE HealthCare | Oct-25 | GE HealthCare introduced advanced contrast-enhanced ultrasound capabilities to its Venue point-of-care systems. By integrating AI-enabled workflow tools specifically for abdominal injury assessment, the company is facilitating faster, more efficient bedside procedures and improving the diagnostic utility of portable ultrasound imaging in critical care environments. |
| Philips | Oct-25 | Philips deployed Elevate software updates across its EPIQ Elite and Affiniti ultrasound platforms. The update integrates advanced AI-powered automation and image optimization features, which are designed to streamline diagnostic workflows and significantly improve image quality, thereby enhancing clinical decision-making and operational efficiency for sonographers. |
| Mindray | Oct-25 | Mindray launched the Resona A20 premium ultrasound system in Europe, expanding its high-end imaging portfolio. This new platform is engineered to deliver superior diagnostic performance, supporting a broad spectrum of complex clinical applications and strengthening the company's competitive position within the premium ultrasound equipment segment. |
| GE HealthCare | Sep-23 | GE HealthCare received a $44 million grant from the Bill & Melinda Gates Foundation to develop AI-assisted ultrasound technology. Led by its subsidiary, Caption Health, the initiative focuses on creating automated tools for maternal, fetal, and respiratory health that function across various devices, including low-cost handheld probes, to expand global access to high-quality diagnostics. |
| Bracco Imaging | Mar-23 | Bracco Imaging announced a strategic expansion of its ultrasound and MRI contrast portfolio, aiming to capture growth in underserved clinical segments. The company is actively partnering with major scanner manufacturers to promote the clinical adoption of ultrasound contrast agents, particularly within the strategic growth markets of China, Japan, and South Korea. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Contrast Enhanced Ultrasound Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Contrast Enhanced Ultrasound Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow much is the contrast enhanced ultrasound market worth?
What is the expected industry size of contrast enhanced ultrasound by 2035?
How is the growing burden of cardiovascular and liver diseases influencing adoption of contrast-enhanced ultrasound?
How are cost and radiation concerns along with microbubble advancements affecting contrast-enhanced ultrasound utilization?
Why does equipment dominate the contrast enhanced ultrasound market?
Why are contrast agents the fastest-growing product segment in the contrast enhanced ultrasound market?
Why does North America dominate the contrast enhanced ultrasound market?
What is fueling contrast enhanced ultrasound market growth in Asia Pacific?
What are the key competitors in the contrast enhanced ultrasound landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization